Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples